Cardiol Therapeutics Inc (CRDL)

May 11, 2025

(CRDL) Strategic Equity Report (CRDL:CA) - news.stocktradersdaily.com

May 11, 2025

May 08, 2025

(CRDL) Advanced Trading Insights (CRDL:CA) - news.stocktradersdaily.com

May 08, 2025

May 08, 2025

Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Consensus Rating of “Buy” by Analysts - Defense World

May 08, 2025

May 06, 2025

Envestnet Asset Management Inc. Makes New Investment in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World

May 06, 2025

May 05, 2025

(CRDL) Market Insights and Trading Signals (CRDL:CA) - news.stocktradersdaily.com

May 05, 2025

May 05, 2025

Lodgement of CONNEQT Pulse Device with the TGA - Investing News Network

May 05, 2025

May 03, 2025

(CRDL) Trading Performance and Risk Management (CRDL:CA) - news.stocktradersdaily.com

May 03, 2025

Apr 30, 2025

(CRDL) Daily Stock Insights (CRDL:CA) - news.stocktradersdaily.com

Apr 30, 2025

Apr 30, 2025

March Quarterly Activities Report - Investing News Network

Apr 30, 2025

Apr 30, 2025

March Quarterly Appendix 4C - Investing News Network

Apr 30, 2025

Apr 30, 2025

Cardiol Therapeutics (TSE:CRDL) Trading Up 6.7% – What’s Next? - Defense World

Apr 30, 2025

Apr 29, 2025

Profound Medical Corp. - Baystreet.ca

Apr 29, 2025

Apr 29, 2025

Cardiol Therapeutics Inc. - Baystreet.ca

Apr 29, 2025

Apr 29, 2025

Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail

Apr 29, 2025

Apr 29, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors | CRDL Stock News - GuruFocus

Apr 29, 2025

Apr 29, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress - TipRanks

Apr 29, 2025

Apr 29, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors - Newsfile

Apr 29, 2025

Apr 29, 2025

Cardiol Therapeutics announces annual shareholder meeting By Investing.com - Investing.com India

Apr 29, 2025

Apr 28, 2025

Cardiol Therapeutics announces annual shareholder meeting - Investing.com

Apr 28, 2025

Apr 28, 2025

Cardiol Therapeutics Schedules Virtual Annual General Meeting for May 2025 - TipRanks

Apr 28, 2025

Apr 27, 2025

First patient dosed in Phase IIb imaging for Brain Mets - Investing News Network

Apr 27, 2025

Apr 27, 2025

(CRDL) Strategic Market Analysis (CRDL:CA) - news.stocktradersdaily.com

Apr 27, 2025

Apr 26, 2025

A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David ElsleyCardiol Therapeutics - thedeepdive.ca

Apr 26, 2025

Apr 25, 2025

Long Term Trading Analysis for (CRDL) (CRDL:CA) - news.stocktradersdaily.com

Apr 25, 2025

Apr 22, 2025

(CRDL) Risk-Controlled Trading Report (CRDL:CA) - news.stocktradersdaily.com

Apr 22, 2025

Apr 22, 2025

Cardiol Therapeutics Stock: Is Cannabis Potential Priced In? - Nasdaq

Apr 22, 2025

Apr 21, 2025

Genocea Biosciences (NASDAQ:GNCA) versus Cardiol Therapeutics (NASDAQ:CRDL) Head-To-Head Review - Defense World

Apr 21, 2025

Apr 19, 2025

(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com

Apr 19, 2025

Apr 19, 2025

Roth Capital Has Bearish Forecast for CRDL Q1 Earnings - Defense World

Apr 19, 2025

Apr 19, 2025

Cardiol Therapeutics (CRDL) Projected to Post Quarterly Earnings on Monday - Defense World

Apr 19, 2025

Apr 18, 2025

Cardiol Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

Apr 18, 2025

Apr 18, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Earns “Buy” Rating from HC Wainwright - Defense World

Apr 18, 2025

Apr 17, 2025

Northwestern University enrols first subject in trial of drug for pericarditis - Yahoo

Apr 17, 2025

Apr 16, 2025

(CRDL) Pivots Trading Plans and Risk Controls (CRDL:CA) - news.stocktradersdaily.com

Apr 16, 2025

Apr 16, 2025

ardiol Therapeutics Inc. - Baystreet.ca

Apr 16, 2025

Apr 16, 2025

Cardiol Therapeutics Commences Phase III Trial for CardiolRx™ in Recurrent Pericarditis - TipRanks

Apr 16, 2025

Apr 16, 2025

Cardiol Therapeutics starts phase III trial for heart drug - Investing.com Australia

Apr 16, 2025

Apr 16, 2025

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis - Newsfile

Apr 16, 2025

Apr 16, 2025

3 Reasons to Sell CSV and 1 Stock to Buy Instead - The Globe and Mail

Apr 16, 2025

Apr 16, 2025

Analysts Set Cardiol Therapeutics Inc. (NASDAQ:CRDL) Price Target at $8.40 - Defense World

Apr 16, 2025

Apr 14, 2025

Cardiol Therapeutics Reports Increased Losses Amid Rising Expenses - TipRanks

Apr 14, 2025

Apr 11, 2025

HC Wainwright Has Negative Outlook for CRDL FY2025 Earnings - Defense World

Apr 11, 2025

Apr 08, 2025

H.C. Wainwright maintains $9 target on Cardiol Therapeutics stock By Investing.com - Investing.com UK

Apr 08, 2025

Apr 08, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Receives “Buy” Rating from HC Wainwright - Defense World

Apr 08, 2025

Apr 08, 2025

Cardiol Therapeutics (TSE:CRDL) Reaches New 1-Year Low – Should You Sell? - Defense World

Apr 08, 2025

Apr 02, 2025

Cardiol Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 02, 2025

Apr 02, 2025

We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate - Yahoo Finance

Apr 02, 2025

Apr 01, 2025

Cardiol Therapeutics advances heart disease treatments By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Stocks In Play: Cardiol Therapeutics Inc. - Barchart.com

Apr 01, 2025

Apr 01, 2025

Cardiol Therapeutics Advances Heart Disease Treatments with Promising Clinical Results - TipRanks

Apr 01, 2025

Apr 01, 2025

Cardiol Therapeutics advances heart disease treatments - Investing.com

Apr 01, 2025